Selected research
Industry Growth & Trends
Global Diltiazem Industry Growth and Trends Forecast to 2032
Market perspective
The global Diltiazem market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Diltiazem is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Diltiazem is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diltiazem is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Diltiazem include Akorn, Athenex, Bausch Health, Hikma Pharmaceuticals, Par Pharmaceutical, Zydus Pharmaceuticals, Pfizer, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Diltiazem market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Diltiazem market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diltiazem market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diltiazem.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Diltiazem market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Diltiazem Market by Company
Akorn
Athenex
Bausch Health
Hikma Pharmaceuticals
Par Pharmaceutical
Zydus Pharmaceuticals
Pfizer
Mylan
Sandoz
Sun Pharma
Teva
Diltiazem Segment by Type
Injection
Tablet
Capsule
Diltiazem Segment by Application
Angina
Hypertension
Diltiazem Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diltiazem market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diltiazem and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diltiazem.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diltiazem manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Diltiazem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablet
- Capsule
Applications
- Angina
- Hypertension
Companies covered
- Akorn
- Athenex
- Bausch Health
- Hikma Pharmaceuticals
- Par Pharmaceutical
- Zydus Pharmaceuticals
- Pfizer
- Mylan
- Sandoz
- Sun Pharma
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Diltiazem Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Diltiazem Sales Estimates and Forecasts (2021-2032)
- 1.3 Diltiazem Market by Type
- 1.3.1 Injection
- 1.3.2 Tablet
- 1.3.3 Capsule
- 1.4 Global Diltiazem Market Size by Type
- 1.4.1 Global Diltiazem Market Size Overview by Type (2021-2032)
- 1.4.2 Global Diltiazem Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Diltiazem Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Diltiazem Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Diltiazem Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Diltiazem Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Diltiazem Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Diltiazem Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Diltiazem Industry Trends
- 2.2 Diltiazem Industry Drivers
- 2.3 Diltiazem Industry Opportunities and Challenges
- 2.4 Diltiazem Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Diltiazem Revenue (2021-2026)
- 3.2 Global Top Players by Diltiazem Sales (2021-2026)
- 3.3 Global Top Players by Diltiazem Price (2021-2026)
- 3.4 Global Diltiazem Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Diltiazem Major Company Production Sites & Headquarters
- 3.6 Global Diltiazem Company, Product Type & Application
- 3.7 Global Diltiazem Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Diltiazem Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Diltiazem Players Market Share by Revenue in 2025
- 3.8.3 2025 Diltiazem Tier 1, Tier 2, and Tier 3
4 Diltiazem Regional Status and Outlook
- 4.1 Global Diltiazem Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Diltiazem Historic Market Size by Region
- 4.2.1 Global Diltiazem Sales in Volume by Region (2021-2026)
- 4.2.2 Global Diltiazem Sales in Value by Region (2021-2026)
- 4.2.3 Global Diltiazem Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Diltiazem Forecasted Market Size by Region
- 4.3.1 Global Diltiazem Sales in Volume by Region (2027-2032)
- 4.3.2 Global Diltiazem Sales in Value by Region (2027-2032)
- 4.3.3 Global Diltiazem Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Diltiazem by Application
- 5.1 Diltiazem Market by Application
- 5.1.1 Angina
- 5.1.2 Hypertension
- 5.2 Global Diltiazem Market Size by Application
- 5.2.1 Global Diltiazem Market Size Overview by Application (2021-2032)
- 5.2.2 Global Diltiazem Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Diltiazem Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Diltiazem Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Diltiazem Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Diltiazem Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Diltiazem Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Diltiazem Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Akorn
- 6.1.1 Akorn Company Information
- 6.1.2 Akorn Business Overview
- 6.1.3 Akorn Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Akorn Diltiazem Product Portfolio
- 6.1.5 Akorn Recent Developments
- 6.2 Athenex
- 6.2.1 Athenex Company Information
- 6.2.2 Athenex Business Overview
- 6.2.3 Athenex Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Athenex Diltiazem Product Portfolio
- 6.2.5 Athenex Recent Developments
- 6.3 Bausch Health
- 6.3.1 Bausch Health Company Information
- 6.3.2 Bausch Health Business Overview
- 6.3.3 Bausch Health Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bausch Health Diltiazem Product Portfolio
- 6.3.5 Bausch Health Recent Developments
- 6.4 Hikma Pharmaceuticals
- 6.4.1 Hikma Pharmaceuticals Company Information
- 6.4.2 Hikma Pharmaceuticals Business Overview
- 6.4.3 Hikma Pharmaceuticals Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hikma Pharmaceuticals Diltiazem Product Portfolio
- 6.4.5 Hikma Pharmaceuticals Recent Developments
- 6.5 Par Pharmaceutical
- 6.5.1 Par Pharmaceutical Company Information
- 6.5.2 Par Pharmaceutical Business Overview
- 6.5.3 Par Pharmaceutical Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Par Pharmaceutical Diltiazem Product Portfolio
- 6.5.5 Par Pharmaceutical Recent Developments
- 6.6 Zydus Pharmaceuticals
- 6.6.1 Zydus Pharmaceuticals Company Information
- 6.6.2 Zydus Pharmaceuticals Business Overview
- 6.6.3 Zydus Pharmaceuticals Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Zydus Pharmaceuticals Diltiazem Product Portfolio
- 6.6.5 Zydus Pharmaceuticals Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Pfizer Diltiazem Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Mylan
- 6.8.1 Mylan Company Information
- 6.8.2 Mylan Business Overview
- 6.8.3 Mylan Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Mylan Diltiazem Product Portfolio
- 6.8.5 Mylan Recent Developments
- 6.9 Sandoz
- 6.9.1 Sandoz Company Information
- 6.9.2 Sandoz Business Overview
- 6.9.3 Sandoz Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sandoz Diltiazem Product Portfolio
- 6.9.5 Sandoz Recent Developments
- 6.10 Sun Pharma
- 6.10.1 Sun Pharma Company Information
- 6.10.2 Sun Pharma Business Overview
- 6.10.3 Sun Pharma Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Sun Pharma Diltiazem Product Portfolio
- 6.10.5 Sun Pharma Recent Developments
- 6.11 Teva
- 6.11.1 Teva Company Information
- 6.11.2 Teva Business Overview
- 6.11.3 Teva Diltiazem Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Teva Diltiazem Product Portfolio
- 6.11.5 Teva Recent Developments
7 North America by Country
- 7.1 North America Diltiazem Sales by Country
- 7.1.1 North America Diltiazem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Diltiazem Sales by Country (2021-2026)
- 7.1.3 North America Diltiazem Sales Forecast by Country (2027-2032)
- 7.2 North America Diltiazem Market Size by Country
- 7.2.1 North America Diltiazem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Diltiazem Market Size by Country (2021-2026)
- 7.2.3 North America Diltiazem Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Diltiazem Sales by Country
- 8.1.1 Europe Diltiazem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Diltiazem Sales by Country (2021-2026)
- 8.1.3 Europe Diltiazem Sales Forecast by Country (2027-2032)
- 8.2 Europe Diltiazem Market Size by Country
- 8.2.1 Europe Diltiazem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Diltiazem Market Size by Country (2021-2026)
- 8.2.3 Europe Diltiazem Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Diltiazem Sales by Country
- 9.1.1 Asia-Pacific Diltiazem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Diltiazem Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Diltiazem Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Diltiazem Market Size by Country
- 9.2.1 Asia-Pacific Diltiazem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Diltiazem Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Diltiazem Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Diltiazem Sales by Country
- 10.1.1 South America Diltiazem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Diltiazem Sales by Country (2021-2026)
- 10.1.3 South America Diltiazem Sales Forecast by Country (2027-2032)
- 10.2 South America Diltiazem Market Size by Country
- 10.2.1 South America Diltiazem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Diltiazem Market Size by Country (2021-2026)
- 10.2.3 South America Diltiazem Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Diltiazem Sales by Country
- 11.1.1 Middle East and Africa Diltiazem Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Diltiazem Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Diltiazem Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Diltiazem Market Size by Country
- 11.2.1 Middle East and Africa Diltiazem Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Diltiazem Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Diltiazem Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Diltiazem Value Chain Analysis
- 12.1.1 Diltiazem Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Diltiazem Production Mode & Process
- 12.2 Diltiazem Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Diltiazem Distributors
- 12.2.3 Diltiazem Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst